Features

Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. We are focusing all our activities and efforts on moving towards our vision of a World Free of Pain.

Grünenthal is a global company headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America, and the U.S. Patients and customers benefit from Grünenthal products in around 100 countries worldwide. In 2025, Grünenthal employed around 4,100 people and achieved revenues of €1.8 bn.